[1] Leonard MP, Jeffs RD, Leventhal B, et al.Pediatric testicular tumors: the Johns Hopkins experience[J]. Urology, 1991, 37(3): 253-256. [2] Sugita Y, Clarnette TD, Cooke-Yarborough C, et al.Testicular and paratesticular tumours in children: 30 years′ experience[J]. Aust N Z J Surg, 1999, 69(7): 505-508. [3] Lee SD, Korean Society of Pediatric Urology. Epidemiological and clinical behavior of prepubertal testicular tumors in Korea[J]. J Urol, 2004, 172(2): 674-678. [4] Mikuz G.Update on the pathology of testicular tumors[J]. Anal Quant Cytopathol Histpathol, 2015, 37(1): 75-85. [5] Kusler KA, Poynter JN.International testicular cancer incidence rates in children, adolescents and young adults[J]. Cancer Epidemiol. 2018, 56: 106-111. [6] Pinto MT, Cárcano FM, Vieira AGS, et al.Molecular Biology of Pediatric and Adult Male Germ Cell Tumors[J]. Cancers (Basel), 2021, 13(10): 2349. [7] 徐雪莲, 叶云林, 郭胜杰, 等. 儿童睾丸良性肿瘤临床分析[J].南方医科大学学报, 2014, 34(9): 1384-1385, 1389. [8] Tröbs RB, Krauss M, Geyer C, et al.Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period[J]. Klin Padiatr, 2007, 219(3): 146-151. [9] Pohl HG, Shukla AR, Metcalf PD, et al.Prepubertal testis tumors: actual prevalence rate of histological types[J]. J Urol, 2004,172(6 Pt 1):2370-2372. [10] Ciftci AO, Bingöl-Koloğlu M, Senocak ME, Tanyel FC, Büyükpamukçu M, Büyükpamukçu N.Testicular tumors in children[J]. J Pediatr Surg, 2001, 36(12): 1796-1801. [11] Karmazyn B, Weatherly DL, Lehnert SJ, et al. Characteristics of testicular tumors in prepubertal children (age 5-12 years) [J]. J Pediatr Urol, 2018, 14(3): 259.e1-259.e6. [12] Cost NG, Lubahn JD, Adibi M, et al.Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors[J]. J Urol, 2014, 191(5 Suppl): 1485-1490. [13] Bundak R, Darendeliler F, Gunoz H, et al.Analysis of puberty and pubertal growth in healthy boys[J]. Eur J Pediatr, 2007, 166(6): 595-600. [14] Isidori AM, Pozza C, Gianfrilli D, et al.Differential diagnosis of nonpalpable testicular lesions: qualitative and quantitative contrast-enhanced US of benign and malignant testicular tumors[J]. Radiology, 2014, 273(2): 606-618. [15] PDQ Pediatric Treatment Editorial Board. Childhood Testicular Cancer Treatment (PDQ®): Patient Version. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-.2019 Dec 12. [16] Ritchey ML, Shamberger RC.Pediatric urologic oncology. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology[C]. 10th ed. Philadelphia: Saunders; 2011: 3696-730. [17] Doridoff AM, Hebra DH, Bumin N, et al.Endodermal sinus lRRior in children[J]. J Pediatr Surg, 1996, 31(8): 1075-1079. [18] J.S.Valla for the Group D′Etude en Urologie Pédiatrique. Testis-sparing surgery for benign testieular tumor in children[J]. J Urol, 2001, 165(6 Pt 2): 2280-2283. [19] Pearse I, Glick RD, Abramson SJ, et al.Teaficularsparing surgery for benign testieular minors[J]. J Pediatr Surg, 1999, 34: l000-1003. [20] 王政, 刘贵麟. 小儿睾丸肿瘤诊疗进展[J]. 临床小儿外科杂志, 2003, 2(5): 351-353. [21] 韦科越, 王从军, 陈超. 儿童原发性睾丸肿瘤47例诊治分析[J]. 现代肿瘤医学, 2017, 25(13): 2079-2082. [22] Rajpert-De Meyts E, McGlynn KA, Okamoto K, et al. Testicular germ cell tumours[J]. Lancet, 2016, 387(10029): 1762-1774. [23] Hires M, Jane E, Mego M, et al.Glycan Analysis as Biomarkers for Testicular Cancer[J]. Diagnostics (Basel), 2019, 9(4): 156. [24] Sturgeon CM, Duffy MJ, Stenman UH, et al.National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers[J]. Clin Chem, 2008, 54(12): e11-79. [25] Maxwell F, Izard V, Ferlicot S, et al.Colour Doppler and ultrasound characteristics of testicular Leydig cell tumours[J]. Br J Radiol, 2016, 89(1062): 20160089. [26] Ambrosini V, Zucchini G, Nicolini S, et al.18F-FDG PET/CT impact on testicular tumours clinical management[J]. Eur J Nucl Med Mol Imaging, 2014, 41(4): 668-673. [27] Dotzauer R, Thomas C, Jager W.The use of F-FDG PET/CT in testicular cancer[J]. Transl Androl Urol, 2018, 7(5): 875-878. [28] Smith ZL, Werntz RP, Eggener SE.Testicular Cancer: Epidemiology, Diagnosis, and Management[J]. Med Clin N Am, 2018, 102(2): 251-264. [29] La Rocca R, Capece M, Spirito L, et al.Testis-sparing surgery for testicular masses: current perspectives[J]. Minerva Urol Nefrol, 2019, 71(4): 359-364. [30] Ye YL, He QM, Zheng FF,et al.Trends of testis-sparing surgery for pediatric testicular tumors in South China[J]. BMC Surg, 2017, 17(1): 31. [31] Schnipper LE, Davidson NE, Wollins DS, et al.American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options[J]. J Clin Oncol, 2015, 33(23): 2563-2577. [32] Delessard M, Saulnier J, Rives A, et al.Exposure to Chemotherapy During Childhood or Adulthood and Consequences on Spermatogenesis and Male Fertility[J]. Int J Mol Sci, 2020, 21(4): 1454. [33] Cushing B, Giller R, Cullen JW, et al.Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children′s Cancer Group 8882[J]. J Clin Oncol, 2004, 22(13): 2691-700. [34] Anderson KH, Romao RLP.Testicular tumors in children and adolescents: long-term endocrine and fertility issues[J]. Transl Androl Urol, 2020, 9(5): 2393-2399. [35] 魏仪. 儿童睾丸肿瘤的诊断与治疗(附137例病例报告)[D]. 重庆医科大学, 2015: 1-40. [36] Boccellino M, Vanacore D, Zappavigna S, et al.Testicular cancer from diagnosis to epigenetic factors[J]. Oncotarget, 2017, 8(61): 104654-104663. |